跳至主要内容
临床试验/NCT01675986
NCT01675986已完成2 期

Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score

Poitiers University Hospital1 个研究点 分布在 1 个国家目标入组 306 人开始时间: 2012年8月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
306
试验地点
1
主要终点
Efficacy treatment

研究概览

简要总结

The insertion of long-lasting intravenous device is done under local anesthesia. Currently, in the investigators hospital, no premedication is given to the patients. However, this procedure occurs in a particular emotional context related to the diagnosis of cancer or malign hemopathies.

Therefore, administration of a sedative or anxiolytic drugs before the start of the procedure can be questionable.

Hydroxyzine is the reference molecule for premedication because of its anxiolytic and anti-histaminic properties A new agent, pregabalin, shares also the same properties

The main objective of this study was to compare the efficacy of pregabalin and hydroxyzine on the anxiety score as a premedication during the insertion of long-lasting intravenous device under local anesthesia.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged from 18 to 75 years
  • Patient schedules for insertion of long-lasting intravenous device

排除标准

  • History of previous insertion of long-lasting intravenous device or central intravenous catheter
  • long term treatment of gabapentin or pregabalin
  • Hypersensitivity to pregabalin or any of the excipients
  • Hypersensitivity to hydroxyzine, one of its metabolites, one of the excipients, another derivative of piperazine, aminophylline or ethylene diamine.
  • Patient at risk of glaucoma e
  • Patient at risk for urinary retention
  • Patient severe respiratory failure
  • Patient at the general condition not too corrupted (ASA IV)
  • Renal failure with creatinin clearance < 30 ml / min
  • Patient not affiliated to Social Security
  • Pregnant or lactating
  • Patients in emergency situations
  • Inpatient without consent

研究组 & 干预措施

Pregabaline

Experimental

Groups PREGABALINE : 150 mg de LYRICA®

干预措施: Pregabalin (Drug)

Hydroxyzine

Experimental

Groups HYDROXYZINE : 75 mg d'ATARAX®

干预措施: hydroxyzine (Drug)

Lactose

Placebo Comparator

Groups placebo : 4 g de lactose

干预措施: Lactose (Drug)

结局指标

主要结局

Efficacy treatment

anxiety score VAS: 0 to 100

次要结局

  • Efficacy of pregabaldin

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验